cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Corbus Pharmaceuticals Holdings Inc
65 own
75 watching
Current Price
$0
$0
(2.55%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
20.6M
52-Week High
52-Week High
0.624
52-Week Low
52-Week Low
0.1
Average Volume
Average Volume
0.14M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization20.6M
icon52-Week High0.624
icon52-Week Low0.1
iconAverage Volume0.14M
iconDividend Yield--
iconP/E Ratio--
What does the Corbus Pharmaceuticals Holdings Inc do?
Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. Its lead product candidate includes JBT-101, a novel oral endocannabinoid-mimetic drug, which is in Phase 2 clinical trials for the treatment of systemic sclerosis, cystic fibrosis, diffuse cutaneous, skin-predominant dermatomyositis, and systemic lupus erythematosus diseases. The company is based in Norwood, Massachusetts.
Read More
How much money does Corbus Pharmaceuticals Holdings Inc make?
News & Events about Corbus Pharmaceuticals Holdings Inc.
PR Newswire
2 months ago
Thinking about buying stock in Nio, Kalera, Salesforce, Corbus Pharmaceuticals, or Full Truck Alliance? Thinking about buying stock in Nio, Kalera, Salesforce, Corbus Pharmaceuticals, or Full Truck Alliance? PR Newswire NEW YORK, Nov. 30, 2022 NEW YORK, Nov. 30, 2022 /PRNewswire...
PR Newswire
3 months ago
Corbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting Corbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting PR Newswire NORWOOD, Mass...
PR Newswire
4 months ago
Thinking about buying stock in Aditxt, RedHill Biopharma, Corbus Pharmaceuticals, Li Auto, or Kiora Pharmaceuticals? Thinking about buying stock in Aditxt, RedHill Biopharma, Corbus Pharmaceuticals, Li Auto, or Kiora Pharmaceuticals? PR Newswire NEW YORK, Sept. 26, 2022 NEW YORK, Sept. 26, 2022...
PR Newswire
4 months ago
Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of Directors Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of Directors PR Newswire NORWOOD, Mass., Sept. 26, 2022 NORWOOD, Mass., Sept. 26, 2022 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP...
PR Newswire
10 months ago
Corbus Presents First Preclinical Data for CRB-601 at the American Association for Cancer Research (AACR) Annual Meeting Corbus Presents First Preclinical Data for CRB-601 at the American Association for Cancer Research (AACR) Annual Meeting PR Newswire NORWOOD, Mass., April 8, 2022 NORWOOD, Mass...
Frequently Asked Questions
Frequently Asked Questions
What is Corbus Pharmaceuticals Holdings Inc share price today?
plus_minus_icon
Can Indians buy Corbus Pharmaceuticals Holdings Inc shares?
plus_minus_icon
How can I buy Corbus Pharmaceuticals Holdings Inc shares from India?
plus_minus_icon
Can Fractional shares of Corbus Pharmaceuticals Holdings Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Corbus Pharmaceuticals Holdings Inc stocks?
plus_minus_icon
What is today’s traded volume of Corbus Pharmaceuticals Holdings Inc?
plus_minus_icon
What is today’s market capitalisation of Corbus Pharmaceuticals Holdings Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Corbus Pharmaceuticals Holdings Inc?
plus_minus_icon
What percentage is Corbus Pharmaceuticals Holdings Inc down from its 52-Week High?
plus_minus_icon
What percentage is Corbus Pharmaceuticals Holdings Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0
(2.55%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00